Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

iodoaryl azidoprazosin

Known as: 2-(4-(4-azido-3-iodobenzoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A convenient method for preparing diverse o-iodoaryl triflates by the desilyliodination of o-silylaryl triflates has been… Expand
Is this relevant?
2012
2012
A catalytic synthesis of novel biaryl-linked divalent glycosides was achieved using an electroreductive palladium-catalyzed… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2003
2003
Agosterol A (AG-A) is a novel agent that reverses P-glycoprotein (P-gp) and multidrug resistance protein-1 (MRP1)-meditated… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
P-Glycoprotein (P-gp) causes a multidrug resistance (MDR) phenotype in tumour cells. In some cancers, the expression of P-gp has… Expand
Is this relevant?
1997
1997
P-glycoprotein (P-gp) mediates a multidrug resistance (MDR) phenotype in tumor cell lines selected with lipophilic cytotoxic… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The multidrug-resistant (MDR) phenotype is characterized in vitro by the resistance displayed by cell lines to a broad spectrum… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1991
1991
P-glycoprotein is an energy-dependent drug efflux pump with broad specificity for hydrophobic antitumor agents such as… Expand
  • table I
  • figure 2
  • figure 1
  • figure 3
  • figure 6
Is this relevant?
1990
1990
P-glycoprotein is a 130-180-kDa integral membrane protein that is overproduced in multidrug-resistant cells. The protein appears… Expand
Is this relevant?